These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2622982)

  • 1. Disruption of FR-40 by 5-HT agonists. I. Effects of chronic imipramine or trazodone.
    Shukla R; Dave V; Mackenzie-Taylor D; Rech RH
    Pharmacol Biochem Behav; 1989 Oct; 34(2):275-81. PubMed ID: 2622982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of FR-40 by 5-HT agonists. II. Effects of chronic phenelzine or isocarboxazid.
    Shukla R; Goudreau J; Mackenzie-Taylor D; Rech RH
    Pharmacol Biochem Behav; 1989 Oct; 34(2):283-7. PubMed ID: 2622983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.
    Alhaider AA; Mustafa AA
    Psychopharmacology (Berl); 1991; 103(3):351-6. PubMed ID: 1647538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic, antihistaminic and cardiovascular effects of two new congeners of quipazine and trazodone.
    Alhaider AA
    Arzneimittelforschung; 1993 Nov; 43(11):1141-4. PubMed ID: 7904818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trazodone, a central serotonin antagonist and agonist.
    Maj J; Palider W; Rawłów
    J Neural Transm; 1979; 44(3):237-48. PubMed ID: 438809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.
    Mokler DJ; Stoudt KW; Rech RH
    Pharmacol Biochem Behav; 1985 May; 22(5):677-82. PubMed ID: 3859879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
    Mokler DJ; Commissaris RL; Henck JW; Rech RH
    Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New hybrids of quipazine and trazodone as selective inhibitors of uptake of 5-hydroxytryptamine.
    Alhaider AA
    J Pharm Sci; 1992 Jan; 81(1):99-103. PubMed ID: 1320118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A characterization of LSD-antagonist effects of pirenperone in the rat.
    Colpaert FC; Janssen PA
    Neuropharmacology; 1983 Aug; 22(8):1001-5. PubMed ID: 6621823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of trazodone (KB-831) and its metabolites on brain monoamines in rat].
    Ikegami A; Maeda A; Hara H; Yamashita A; Sukamoto T; Ito K
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):145-54. PubMed ID: 2731805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of trazodone with serotonin neurons and receptors.
    Fuller RW; Snoddy HD; Cohen ML
    Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic treatment with imipramine, trazodone and electroshock on the behavioural and electroencephalographic modifications induced by clonidine in the rat.
    Passarelli F; Scotti de Carolis A
    Neuropharmacology; 1983 Jun; 22(6):785-9. PubMed ID: 6684221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
    McKearney JW
    Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of the effects of antidepressants on the GABAA receptor and its complex based on the drug actions on the power-spectral changes of rat hippocampal EEG induced by GABA antagonists and inverse agonists].
    Matsubara M; Suzuki S; Miura K; Terashima M; Hatsuda S; Sugita S; Murakami H; Nakazawa K; Ohara M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):75-83. PubMed ID: 9201727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclazocine disruption of operant behavior is antagonized by naloxone and metergoline.
    Henck JW; Mokler DJ; Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1983 Jan; 18(1):41-5. PubMed ID: 6828536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
    Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.
    Zahorodna A; Tokarski K; Bijak M
    Eur J Pharmacol; 2002 May; 443(1-3):51-7. PubMed ID: 12044792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.